GenSight Biologics Announces the Filing of its 2024 Universal Registration Document

GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update

GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates

GenSight Biologics announces financing amounting to c. €0.9 million from existing investors

GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results

GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update

GenSight Biologics announces a financing for an amount of c. €1.5 million from existing investors

GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation

GenSight Biologics announces a financing for an amount of c. €2.8 million from existing investors

GenSight Biologics Reports Cash Position as of September 30, 2024, and Provides Business Update